Pharmacogenomics Testing

DIAGNOSTIC_TEST3 trials

Sponsors

Anderson Orthopaedic Research Institute, Mayo Clinic, Nalagenetics Pte Ltd

Conditions

Arthroplasty ComplicationsPalliative MedicinePre-emptive Pharmacogenomics

Phase 3

Pharmacogenetics for Pain Management in Joint Replacement Patients

Anderson Orthopaedic Research InstituteArthroplasty Complications

Start: 2018-12-03End: 2021-12-31Updated: 2021-02-12

Unknown Phase

The Role of the Pharmacist and Pharmacogenomics in the Care of Seriously Ill Patients

TerminatedNCT04251520

Mayo ClinicPalliative Medicine

Start: 2021-04-15End: 2022-01-12Updated: 2022-05-05

Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (IMPT Study)

CompletedNCT05504135

Nalagenetics Pte LtdPre-emptive Pharmacogenomics

Start: 2022-10-03End: 2024-08-31Updated: 2025-05-30

Related Papers

A feasibility study on implementing pre-emptive pharmacogenomics testing in outpatient clinics in Singapore (IMPT study)

The Pharmacogenomics Journal2025-03-122 citations